Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Reversal of Declining Cardiovascular Disease Mortality Rates

According to a study published online in the American Journal of Preventive Medicine, declines in cardiovascular disease (CVD) mortality observed from 2010 to 2019 were reversed in 2020 and persisted through 2022. The study, conducted by Rebecca C. Woodruff, Ph.D., and colleagues from the U.S. Centers for Disease Control and Prevention, utilized national mortality data from the National Vital Statistics System to analyze temporal trends in CVD death rates.

During the period of 2010 to 2022, there were a total of 10,951,403 CVD deaths, with 75.6 percent attributed to heart disease and 16.9 percent to stroke. The national CVD age-adjusted mortality rate exhibited an 8.9 percent decrease from 456.6 to 416.0 per 100,000 from 2010 to 2019. However, this was followed by a 9.3 percent increase to 454.5 per 100,000 in 2022, indicating a reversal in the declining trend.

Notably, there were 228,524 excess CVD deaths from 2020 to 2022, representing a 9 percent increase compared to the expected numbers based on the trends observed from 2010 to 2019. The study also highlighted variations in the results by CVD subtype and population subgroup.

The authors of the study emphasized the enduring and widespread increases in CVD mortality during the initial years of the COVID-19 pandemic, urging the prioritization of prevention, detection, and treatment of chronic and acute CVD to address the persistent adverse trends observed during this period.

This study sheds light on the concerning reversal of declining CVD mortality rates and the impact of the COVID-19 pandemic on cardiovascular health. The findings underscore the importance of addressing the challenges posed by the pandemic on CVD prevention and treatment.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *